CompletedNCT00045916
Two ECT approaches with medication for a major depressive episode
About this title
Read the official source — NCT00045916Medication studyAges 18+United StatesDepression
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- St Louis and 3 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateFebruary 2001
- Recruitment status
- Completed
- Enrollment listed in the registry
- 340
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug, Procedure
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT00045916
- Official title
Show the full official title
Optimization of Electroconvulsive Therapy
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
St Louis · New York · Winston-Salem
1 more locations
- Pittsburgh
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Did this study involve medication?
Yes. The study involved medication, including Nortriptyline, Venlafaxine and lithium.
Who was this study for?
Listed age limits: from 18 years.
